课题基金 / 基金详情

Elucidating the role of Lrrc34 in the regulation of ribosome biogenesis and Oct4 in mouse and human pluripotent stem cells

Elucidating the role of Lrrc34 in the regulation of ribosome biogenesis and Oct4 in mouse and human pluripotent stem cells
阐明 Lrrc34 在小鼠和人类多能干细胞核糖体生物合成和 Oct4 调节中的作用
批准号:
323786205
负责人:
Dr. Jessica Nolte
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31

项目摘要

项目成果

Dr. Jessica Nolte的其他基金

相似基金

相关文献

中文摘要
翻译
在本基金的框架内,将重点分析基因Lrrc34在多能干细胞核仁中的功能。到目前为止,人们对该基因知之甚少:它只在干细胞和男性生殖细胞中表达,其蛋白质主要位于核仁中。研究表明,调控flrrc34的表达可导致胚胎干细胞的差异生长和多能性基因(如Oct4)的表达改变。由于核核是核糖体生物发生的地方,Lrrc34在核糖体生物发生中的作用将被研究。进一步分析Oct4的调控及与Oct4的相互作用。为此,体外试验(小鼠和人类)以及敲除小鼠模型的生成和表征将被使用。
英文摘要
In the frame of the presented grant it will be the focus to analyze thefunction of the gene Lrrc34 in the nucleolus of pluripotent stem cells.Up till know there is not much known about the gene: it is exclusivelyexpressed in stem cells and male germ cells and its protein ispredominantly located in the nucleolus. It is shown, that regulation ofLrrc34 expression resulted in differentially growing of embryonic stemcells and an altered expression of pluripotency genes (e.g. Oct4).Since the nucleolus is the place of ribosome biogenesis,the role of Lrrc34 in ribosome biogenesis will beinvestigated. Furthermore the regulation of and interaction with Oct4 will be further analysed. For this, in vitro assays (mouse and human) as well as the generation and characterization of a knock-out mouse model will be used.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Lrrc34 interacts with Oct4 and has an impact on telomere length in mouse Embryonic Stem Cells.
Lrrc34 与 Oct4 相互作用并对小鼠胚胎干细胞中的端粒长度产生影响
DOI: 10.1089/scd.2021.0113
发表时间: 2021
期刊: Stem cells and development
影响因子: 4
作者: []
通讯作者:
Zum Potential spermatogonialer Stammzellen
Characterization of putative pluripotency-regulating genes and defining the role of germ cell-specific genes during reprogramming
  • 批准号:
    66168673
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Dr. Jessica Nolte
  • 依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
  • 批准号:
    82371070
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵培泉
  • 依托单位: